Journal of Liver

3^rd World Congress on Hepatitis and Liver Diseases

October 10-12, 2016 Dubai, UAE

Scientific Tracks Abstracts

• Increase of specific social score EPICES before and after direct antiviral agent treatment in HCV patients in France: Two years experience

  Bouchkira Hakim

  PDF HTML

• Hepatitis C Virus (HCV) genotype 1b as a risk factor for hepatocellular carcinoma development in chronic HCV positive patients in Southern Italy

  Arnolfo Petruzziello, Marigliano S , Loquercio G, Guarino R, Izzo F and Cacciapuoti C

  PDF HTML

• Hepatitis E virus infection: An underestimated evolving problem

  Fatma Abdelaziz Amer

  PDF HTML

• Nucleic acid polymers: Application in the treatment of chronic HBV and HBV/HDV infection and potentiating the effects of immunotherapy

  Andrew Vaillant

  PDF HTML

• Direct-acting antivirals Ombitasvir/Paritaprevir/Ritonavir+Dasabuvir with or without Ribavirin in HCV genotype 1-infected treatment-naive or treatment-experienced patients with or without cirrhosis

  Ligita Jancoriene, Katazyna Polubenko, Edita Kazenaite, Arida Buivydiene, Jolita Jakutiene, Ieva Tolmane and Agita Jeruma

  PDF HTML

• Current therapeutic approaches to NAFLD treatment

  Asad Izziddin Dajani

  PDF HTML

• Hepatitis B revaccination to students whom firstly demonstrated anti-HBs negative or titer <10 mIU/ml

  Prapan Jutavijittum

  PDF HTML

• Hepatitis B revaccination to students whom firstly demonstrated anti-HBs negative or titer <10 mIU/ml

  Prapan Jutavijittum

  PDF HTML

• Therapeutic trial to assess the efficacy and safety of folic acid and/or vitamin B complex on hepatitis C infected patients treated with pegylated interferon and Ribavirin

  Nermeen Nabil Ashoush

  PDF HTML

• Potent and broad spectrum medicinal drugs against all genotypes of hepatitis C virus (HCV)

  Mahmoud Fahmi Elsebai

  PDF HTML

• Circulating microRNAs as non-invasive biomarkers for the detection of different stages of liver fibrosis in Egyptian HCV patients

  Eman El-Ahwany

  PDF HTML

• Economic Evaluation in Health and Medicine

  Nermeen Nabil Ashoush

  PDF HTML

• Hepatitis mobile team: A new concept for benefit toward drugs users and precarious people with hepatitis C in France

  Andre-Jean Remy, Bouchkira Hakim, Montabone Stephane and Lamarre Patrice

  PDF HTML

• Treating patients with hepatitis C genotype 1 using Viekira Pakâ?¢ in the real world: An Australian nursing perspective

  Fragomeli V, Nazareth S, Leembruggen N, Jones T, Mason S, How-Chow D, Colman A, Warner S, Tilley E and Altus R

  PDF HTML

• New insights into the roadmap of pathogenesis of liver fibrosis

  Eman El-Ahwany

  PDF HTML

• 40 years observation in liver diseases in the Middle East

  Makki H Fayadh

  PDF HTML

• Genetics in hepatitis B

  Osama Hasan Othman

  PDF HTML

• Matrine eliminates hepatosteatosis and glucose intolerance in high fructose-fed mice by suppressing ER stress associated de novo lipogenesis in the liver

  Ali Mahzari, XiaoyiZeng, Songpei Li, Charlie Changli Xue and Jiming Ye

  PDF HTML